SignatureFD
TGTX icon

SignatureFD’s TG Therapeutics TGTX Stock Holding History

SignatureFD’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.9K Buy
1,092
+720
+194% +$39K ﹤0.01% 1848
2026
Q2 		$20.4K Buy
372
+213
+134% +$8.72K ﹤0.01% 2335
2026
Q1 		$5.28K Buy
159
+124
+354% +$3.7K ﹤0.01% 2760
2025
Q4 		$1.04K Buy
35
+1
+3% +$33 ﹤0.01% 3112
2025
Q3 		$1.23K Sell
34
-14
-29% -$461 ﹤0.01% 3047
2025
Q2 		$1.73K Buy
48
+13
+37% +$484 ﹤0.01% 2910
2025
Q1 		$1.38K Sell
35
-41
-54% -$1.38K ﹤0.01% 2973
2024
Q4 		$2.29K Buy
76
+44
+138% +$1.26K ﹤0.01% 2832
2024
Q3 		$748 Buy
32
+6
+23% +$131 ﹤0.01% 3044
2024
Q2 		$463 Sell
26
-52
-67% -$830 ﹤0.01% 2992
2024
Q1 		$1.19K Buy
+78
New +$1.24K ﹤0.01% 2923
2022
Q2 		– Sell
-532
Closed -$5K – 3343
2022
Q1 		$5K Buy
532
+187
+54% +$2.16K ﹤0.01% 2515
2021
Q4 		$7K Sell
345
-2
-0.6% -$52 ﹤0.01% 2291
2021
Q3 		$12K Buy
347
+21
+6% +$650 ﹤0.01% 1989
2021
Q2 		$13K Sell
326
-67
-17% -$2.63K ﹤0.01% 1904
2021
Q1 		$19K Buy
393
+80
+26% +$3.84K ﹤0.01% 1596
2020
Q4 		$16K Hold
313
– – ﹤0.01% 1535
2020
Q3 		$8K Hold
313
– – ﹤0.01% 1744
2020
Q2 		$6K Buy
313
+50
+19% +$805 ﹤0.01% 1755
2020
Q1 		$3K Buy
+263
New +$3.32K ﹤0.01% 1861

Other funds holding TGTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

SignatureFD's TGTX Position: Q3 2026 in Review

SignatureFD increased its TG Therapeutics (TGTX) stake by 194% in Q3 2026, buying an estimated $39K and bringing the position to 1,092 shares worth $60.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

SignatureFD first reported a position in TGTX in Q1 2020 and has held it in 20 quarters since. 361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • SignatureFD held 1,092 shares of TG Therapeutics worth $60.9K as of Q3 2026.
  • SignatureFD bought 720 TG Therapeutics shares in Q3 2026, an estimated $39K.
  • TG Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1848 holding.
  • SignatureFD first reported a position in TG Therapeutics in Q1 2020 and has held it in 20 quarters since.
  • 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.